ONCOLOGY
Allovectin-7® Phase 3 Clinical Trial: The Allovectin-7® Immunotherapeutic for Metastatic Melanoma (A.I.M.M.) Trial
A Phase 3 clinical trial to evaluate the safety and efficacy of Allovectin-7® compared to dacarbazine (DTIC) or temozolomide (TMZ) in subjects with Stage 3 or Stage 4 melanoma.
IL-2 EP Phase 1 Clinical Trial: IM01-101
A Phase 1 clinical trial to evaluate the safety of intratumoral VCL-IM01 (an interleukin-2 gene-based product) followed by electroporation in metastatic melanoma.
For more information, please go to:
http://www.clinicaltrials.gov/ct/show/NCT00223899?order=1
INFECTIOUS DISEASES
Cytomegalovirus (CMV) Phase 2 Clinical Trial: CB01-202
A Phase 2 clinical trial to evaluate the safety, immunogenicity, and clinical benefit of a CMV immunotherapeutic vaccine in donors and CMV-seropositive recipients undergoing allogeneic, matched, related hematopoietic cell transplant (HCT).
For more information, please go to:
http://www.clinicaltrials.gov/ct/show/NCT00285259?order=1
Pandemic Influenza Phase 1 Clinical Trial: IPT1-101
A Phase 1 clinical trial to evaluate the safety, tolerability, and immunogenicity of pandemic influenza plasmid DNA vaccines.